Michele Millham

Michele Millham has extensive work experience in the field of molecular biology and Next Generation Sequencing. Michele has held various roles in renowned companies such as Detect, IsoPlexis, Quantum-Si, Thermo Fisher Scientific, Ion Torrent by Life Technologies, Pfizer, and Bayer Pharmaceuticals.

Starting with their most recent position, Millham joined Detect in 2023 as a Staff Scientist. Prior to this, they worked at IsoPlexis as a Principal Scientist from 2022 to 2023. In this role, they focused on research and development for a novel product, mentored team members, and collaborated with engineering and manufacturing to improve automation processes.

From 2018 to 2022, Millham worked at Quantum-Si, first as a Staff Scientist and later as a Senior Scientist Molecular Biology. Here, they led a team to create new applications for an automated instrument and optimized manual workflows for sequencing. Michele collaborated with cross-functional teams to develop functionalized peptide libraries.

Before Quantum-Si, Millham was a Staff Scientist at Thermo Fisher Scientific from 2014 to 2018. Michele'sresponsibilities included research and development in the Molecular Biology group for Next Generation Sequencing. Michele verified and validated new applications, developed methods and technology improvements, and supported oncology precision medicine studies.

Prior to Thermo Fisher Scientific, Millham worked at Ion Torrent by Life Technologies as a Scientist II from 2011 to 2014. Here, they focused on research and development for cancer mutation sequencing products and provided training for early access customers. Michele also contributed to hands-free sample preparation innovations.

Earlier in their career, Millham held positions at Pfizer as a Senior Scientist from 1997 to 2011 and at Bayer Pharmaceuticals as an Associate Scientist from 1994 to 1997. Michele started their career as a Laboratory Technician II at the University of Vermont from 1990 to 1994.

Overall, Millham's work experience spans multiple roles in molecular biology, Next Generation Sequencing, and pharmaceutical companies. Michele has demonstrated expertise in research and development, automation, mentoring, and collaboration with cross-functional teams.

Michele Millham completed their Bachelor of Science degree in Biochemistry from the University of New Hampshire, where they studied from 1985 to 1989. Michele later pursued a Master of Arts degree in Biology from Brown University, from 1997 to 2000.